Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Drug Name | LFM-A13 |
Trade Name | |
Synonyms | |
Drug Descriptions |
LFM-A13 inhibits BTK, with additional activity against JAK2 and PLK, potentially resulting in increased tumor cell apoptosis (PMID: 17098432, PMID: 15196000, PMID: 10092645, PMID: 30571407). |
DrugClasses | BTK inhibitor 36 JAK2 Inhibitor 17 |
CAS Registry Number | 244240-24-2 |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Epoetin beta + LFM-A13 | Epoetin beta LFM-A13 | 0 | 0 |
LFM-A13 | LFM-A13 | 0 | 0 |